Forty-six patients with T1 and T2 carcinomas of the floor of mouth (FOM), who underwent brachytherapy from February, 1979 to March, 1991, were reviewed retrospectively.
Four of the 46 patients died within 2 years of their initial treatment, without a local recurrence and/or radiation injury. Therefore, they were excluded from the evaluation of two-year local control and radiation injury rate.
The two-year local control rate of the remaining 42 patients was 93%(39/42). The rate was 100%(27/27) in patients treated by brachytherapy (BT) alone, and 80%(12/15) in those treated by BT with external radiation (ERT) and chemotherapy. This rate was not elevated from that achieved at a dose of 70 Gy by BT (88%) when a dose of 80 Gy was given by BT with ERT (90%) in the dose-response relationship.
According to tumor extension, the local control rates for pelvic-gingival (PG), pelvic (P) and pelvic-lingual (PL) tumors were 75%(6/8), 100%(19/19) and 93%(14/15), respectively (N.S.). The two-year radiation injury (mandibular exposure) rate was 10%(4/42). The rate was 7%(2/27) in patients treated by BT alone and 13%(2/15) in those treated by BT with ERT, and was greatly elevated from that occurring with a dose of 70 Gy by BT (5%) when a dose of 80 Gy was given by BT with ERT (13%) in the dose-response relationship.
According to tumor extension, the radiation injury rates for PG, P and PL tumors were 13%(1/8), 5%(1/19) and 13%(2/15), respectively (N.S.).
In conclusion, BT with ERT did not improve the local control rate of T1 and T2 carcinomas of FOM, and elevated the radiation injury rate greatly. Therefore, we believe that T1 and T2 carcinoma, even when extending to the gingiva, should be treated by BT alone.
Multiple cancer incidence in these patients was 28%(13/46), and the incidence of digestive tract cancer was especially high.
Therefore, a complete work-up is necessary before treatment and during the follow-up period.
View full abstract